Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Patients with schizophrenia who take antipsychotic drugs are more
likely to have a cardiac arrest or ventricular arrhythmia than control
patients. Hennessy and colleagues (p 1070) studied people enrolled with
three US Medicaid programmes to compare the risks of schizophrenic
patients with those of patients with psoriasis and glaucoma and the
risks of different antipsychotic drugs. Prolongation of the QT interval
is often used as a marker of cardiac risk for these drugs. The study
found that although thioridazine prolongs the QT interval more than
haloperidol, the cardiac risk of the two drugs was similar except at
high doses. The authors advise doctors to prescribe the lowest dose of
thioridazine necessary.